iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Brookstone Capital Management

Brookstone Capital Management decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 1.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,629 shares of the financial services provider’s stock after selling 124 shares during the period. Brookstone Capital Management’s holdings in iShares Biotechnology ETF were worth $910,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Pacifica Partners Inc. increased its position in iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares in the last quarter. Crewe Advisors LLC increased its position in iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares in the last quarter. Northwest Financial Advisors purchased a new position in iShares Biotechnology ETF during the fourth quarter worth $42,000. Values First Advisors Inc. purchased a new position in iShares Biotechnology ETF during the fourth quarter worth $43,000. Finally, Tennessee Valley Asset Management Partners purchased a new position in iShares Biotechnology ETF during the fourth quarter worth $44,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.5 %

Shares of NASDAQ:IBB opened at $137.26 on Friday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The business has a fifty day simple moving average of $134.42 and a 200-day simple moving average of $134.88.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Articles

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.